
There are a lot of clichés about the value of a good teacher. But Mark Krotec, who has been teaching science for 45 years at Central Catholic High School in Pittsburgh, seems to prove them true. In one small Advanced Placement biology class taught in the early 2010s, three of his students went on to pursue a Ph.D. and three more to get an M.D.-Ph.D.
Among the latter was Neil Carleton, who credits the two courses of Krotec’s he took in high school — which dove deep into physiology and anatomy rather than the standard curriculum — with igniting a passion for medicine that grew even bigger than his love for ice hockey, eventually making him a rising star in the research of cancer in older women. “I think he planted a seed,” Carleton said.
Fittingly, the most consequential among Carleton’s prolific body of research so far — comprising 20 research papers, seven as lead author — was sparked by a simple question that seemed to be waiting for a curious student to ask: How come about 40% of breast cancers are diagnosed in women above 65, and out of them, 80% are estrogen-receptive, if postmenopausal women have low levels of estrogen?
His Ph.D. thesis found an answer — “elegant and rigorously supported,” in his adviser’s words: Due to aging and inflammation processes, patients have high levels of an enzyme that converts estrone, a weak female hormone, in estradiol, the strongest and most active type of estrogen in the female body, feeding the tumor. It adds an important piece in the puzzle of the biology of cancer, pointing toward possible treatments — or even, he said with cautious excitement, prevention.